9P6Q | pdb_00009p6q

Mouse Ketohexokinase-A without ligand


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.37 Å
  • R-Value Free: 
    0.188 (Depositor), 0.211 (DCC) 
  • R-Value Work: 
    0.149 (Depositor) 
  • R-Value Observed: 
    0.151 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 9P6Q

This is version 1.0 of the entry. See complete history

Literature

Conformational changes in ketohexokinase are conserved across isozymes and species.

Bae, S.Y.Allen, K.N.Tolan, D.R.

(2025) Acta Crystallogr F Struct Biol Commun 81: 451-458

  • DOI: https://doi.org/10.1107/S2053230X25008428
  • Primary Citation Related Structures: 
    9P6Q

  • PubMed Abstract: 

    Ketohexokinase (KHK) catalyses the initial step in fructose metabolism, converting the furanose form of D-fructose to fructose 1-phosphate in an ATP-dependent reaction. Given its central role in metabolic pathways, KHK has emerged as a target for pharmacological intervention in the treatment of non-alcoholic fatty liver disease, metabolic syndrome, type 2 diabetes and obesity. KHK exists as two isoforms, A and C, which arise from alternative splicing of exon 3, resulting in a differing 45-amino-acid sequence within the 298-amino-acid primary structure of the enzyme. KHK is a biological homodimer, with each subunit adopting an α/β-fold architecture that interlocks with a β-clasp domain. In the case of KHK-C at least two distinct conformations of the β-clasp domain have been identified, whereas this conformational flexibility had not been observed in KHK-A. Here, X-ray crystallographic structural investigations of unliganded murine KHK-A refined to 1.37 Å resolution revealed the adoption of two conformations similar to those adopted by the human ortholog, suggesting that this structural feature is conserved across species. The functional significance of these conformational changes in KHK-A is of particular interest as this isoform has been implicated in cancer metastasis through a `moonlighting' protein kinase activity. Understanding the mechanistic role of conformational shifts in KHK-A may provide insights into its broader physiological functions and therapeutic potential.


  • Organizational Affiliation
    • Program in Molecular Biology, Cell Biology, and Biochemistry, Boston University, Boston, MA 02215, USA.

Macromolecule Content 

  • Total Structure Weight: 34.94 kDa 
  • Atom Count: 2,632 
  • Modeled Residue Count: 296 
  • Deposited Residue Count: 318 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Ketohexokinase318Mus musculusMutation(s): 0 
Gene Names: Khk
EC: 2.7.1.3

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.37 Å
  • R-Value Free:  0.188 (Depositor), 0.211 (DCC) 
  • R-Value Work:  0.149 (Depositor) 
  • R-Value Observed: 0.151 (Depositor) 
Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 42.066α = 90
b = 78.659β = 90
c = 150.553γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
PDB_EXTRACTdata extraction
autoPROCdata reduction
autoPROCdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA)United StatesU01AA027997

Revision History  (Full details and data files)

  • Version 1.0: 2025-11-12
    Type: Initial release